A group of high blood pressure researchers is ending its 16-year relationship with a high blood pressure journal, and claims of improper drug company influence on doctors are at the root of the dispute.
The Wall Street Journal has details.
Dr. John Laragh, co-founder of the American Journal of Hypertension, complains that some doctors have become "heavily involved in pharma marketing for personal gain."
As the Journal appropriately frames the story, it is "a dispute reflecting heightened concerns about the control and credibility of medical information."
Leave a comment
My policy on commentsI'm adopting the policy of a blog I admire: “Comments are great; obnoxious comments get deleted. Deal." I also won’t post profanity, product pitches, or anything from anyone who doesn’t list what appears to be an actual e-mail address.